Multifunctionality of PAI-1 in fibrogenesis:: Evidence from obstructive nephropathy in PAI-1-overexpressing mice

被引:117
作者
Matsuo, S
López-Guisa, JM
Cai, XH
Okamura, DM
Alpers, CE
Bumgarner, RE
Peters, MA
Zhang, GQ
Eddy, AA
机构
[1] Univ Washington, Dept Pediat, Seattle, WA 98105 USA
[2] Childrens Hosp & Reg Med Ctr, Seattle, WA 98105 USA
[3] Univ Washington, Dept Pathol, Seattle, WA 98105 USA
[4] Univ Washington, Dept Microbiol, Seattle, WA 98105 USA
关键词
interstitial fibrosis; plasminogen activator inhibitor-1; macrophage; urokinase; unilateral ureteral obstruction;
D O I
10.1111/j.1523-1755.2005.00327.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Plasminogen activator inhibitor-1 (PAI-1) has been implicated in the pathogenesis of chronic kidney disease based on its up-regulated expression and on the beneficial effects of PAI-1 inhibition or depletion in experimental models. PAI-1 is a multifunctional protein and the mechanisms that account for its profibrotic effects have not been fully elucidated. Methods. The present study was designed to investigate PAI-1-dependent fibrogenic pathways by comparing the unilateral ureteral obstruction model (UUO) (days 3, 7, and 14) in PAI-I-overexpressing mice (PAI-1 tg) to wild-type mice, both on a C57BL6 background. Results. Following UUO, total kidney PAI-1 mRNA and/or protein levels were significantly higher in the PAI-1 tg mice (N = 6 to 8/group) and fibrosis severity was significantly worse (days 3, 7, and 14), measured both as Sirius red-positive interstitial area (e.g., 10 +/- 3.2% vs. 4.5 +/- 1.0%) (day 14) and total kidney collagen (e.g., 11.1 +/- 1.7 vs. 6.2 +/- 1.3 mu g/mg) (day 14). By day 14, the expression of two normal tubular proteins, E-cadherin and Ksp-cadherin, were significantly lower in the PAI-1 tg mice (3.2 +/- 0.5% vs. 11.7 +/- 5.9% and 2.6 +/- 1.6) vs. 6.2 +/- 0.8%, respectively), implying more extensive tubular damage. At least four fibrogenic pathways were differentially expressed in the PAI-1 tg mice. First, interstitial macrophage recruitment was more intense (P < 0.05 days 3 and 14). Second, interstitial myofibroblast density was greater (P < 0.05 days 3 and 7) despite similar numbers of proliferating tubulointerstitial cells. Third, transforming growth factor-beta 1 (TGF-beta 1) and collagen I mRNA were significantly higher. Finally, urokinase activity was significantly lower (P < 0.05 days 7 and 14) despite similar mRNA levels. Gene microarray studies documented that that the deletion of this single profibrotic gene had far-reaching consequences on renal cellular responses to chronic injury. Conclusion. These data provide further evidence that PAI-1 is directly involved in interstitial fibrosis and tubular damage via two primary overlapping mechanisms: early effects on interstitial cell recruitment and late effects associated with decreased urokinase activity.
引用
收藏
页码:2221 / 2238
页数:18
相关论文
共 47 条
[41]   MiR-10a and miR-181c regulate collagen type I generation in hypertrophic scars by targeting PAI-1 and uPA [J].
Li, Chao ;
Zhu, Hua-Yu ;
Bai, Wen-Dong ;
Su, Lin-Lin ;
Liu, Jia-Qi ;
Cai, Wei-Xia ;
Zhao, Bin ;
Gao, Jian-Xin ;
Han, Shi-Chao ;
Li, Jun ;
Hu, Da-Hai .
FEBS LETTERS, 2015, 589 (03) :380-389
[42]   Time varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer [J].
Schmitt, M ;
Thomssen, C ;
Ulm, K ;
Seiderer, A ;
Harbeck, N ;
Hofler, H ;
Janicke, F ;
Graeff, H .
BRITISH JOURNAL OF CANCER, 1997, 76 (03) :306-311
[43]   Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8 [J].
Wang, Hao-Chen ;
Lin, Yung-Lun ;
Hsu, Ching-Cheng ;
Chao, Ying-Jui ;
Hou, Ya-Chin ;
Chiu, Tai-Jan ;
Huang, Po-Hsien ;
Tang, Ming-Jer ;
Chen, Li-Tzong ;
Shan, Yan-Shen .
THERANOSTICS, 2019, 9 (24) :7168-7183
[44]   Optimized immunohistochemistry in combination with image analysis: A reliable alternative to quantitative ELISA determination of uPA and PAI-1 for routine risk group discrimination in breast cancer [J].
Lang, D. S. ;
Heilenkoetter, U. ;
Schumm, W. ;
Behrens, O. ;
Simon, R. ;
Vollmer, E. ;
Goldmann, T. .
BREAST, 2013, 22 (05) :736-743
[45]   A Citrus Extract Containing Flavanones Represses Plasminogen Activator Inhibitor-1 (PAI-1) Expression and Regulates Multiple Inflammatory, Tissue Repair, and Fibrosis Genes in Human Colon Fibroblasts [J].
Gimenez-Bastida, Juan A. ;
Martinez-Florensa, Mario ;
Espin, Juan-Carlos ;
Tomas-Barberan, Francisco A. ;
Garcia-Conesa, Maria-Teresa .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2009, 57 (19) :9305-9315
[46]   Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1) [J].
Borgfeldt, C ;
Hansson, SR ;
Gustavsson, B ;
Måsbäck, A ;
Casslén, B .
INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (04) :497-502
[47]   Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk [J].
Sekiguchi, Fumiko ;
Domoto, Risa ;
Nakashima, Kana ;
Yamasoba, Daichi ;
Yamanishi, Hiroki ;
Tsubota, Maho ;
Wake, Hidenori ;
Nishibori, Masahiro ;
Kawabata, Atsufumi .
NEUROPHARMACOLOGY, 2018, 141 :201-213